{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for tedizolid root_relationships_relatedSubstance_refPname in Related Substance Name (approximate match)
Status:
Possibly Marketed Outside US
First approved in 1983
Source:
NADA125961
Source URL:
Class:
MIXTURE
Status:
US Approved Rx
(2017)
Source:
BLA761047
(2017)
Source URL:
First approved in 2017
Source:
BLA761047
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2015)
Source:
BLA125513
(2015)
Source URL:
First approved in 2015
Source:
BLA125513
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:upinitatug rilsodotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
USAN:LIFASTUZUMAB [USAN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:lifastuzumab vedotin [INN]
Source URL:
Class:
PROTEIN